Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases
Open Closes November 5, 2026 (5 days left)
Centers for Disease Control and Prevention - ERA is offering grants of up to $6.0 million (at least $1.8 million) to nonprofits, colleges and universities, state and local governments, tribes and businesses. It expects to make about 2 awards worth $30.0 million in total. Applications close on November 5, 2026.
From the official notice on Grants.gov, last changed August 3, 2026. Checked October 31, 2026.
- Award ceiling$6.0 million
- Award floor$1.8 million
- Expected awards2
- Total funding$30.0 million
- Cost sharingNot required
- Funding typeCooperative Agreement
Key dates
| Posted | August 3, 2026 |
|---|---|
| Deadline | November 5, 2026 |
| Archived by Grants.gov | December 7, 2026 |
Add the deadline to your calendar
Who can apply
This opportunity is open to nonprofits, colleges and universities, state and local governments, tribes and businesses.
- State governments
- County governments
- City or township governments
- Special district governments
- Independent school districts
- Public and State controlled institutions of higher education
- Native American tribal governments (Federally recognized)
- Public housing authorities/Indian housing authorities
- Native American tribal organizations (other than Federally recognized tribal governments)
- Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education
- Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
- Private institutions of higher education
- For profit organizations other than small businesses
Is this a realistic fit?
- No cost sharing or match is required.
What the grant funds
The focus of this notice of funding opportunity (NOFO) is to produce insights into disease detection and prevention strategies, burden, severity, diagnostics, treatment, and outcomes of infectious diseases in international travelers. Timely surveillance and sentinel detection are essential for collecting actionable data. The research should:Address public health questions that improve the speed of outbreak detection. Help develop guidelines and recommendations to improve patient care. Enhance understanding of the natural history of disease. Optimize genomic surveillance as well as diagnostic and treatment strategies. Advance the global health security of the United States. This NOFO will have two components:Component A – Clinic-based sentinel network. Component B – Sentinel detection in international transportation hubs. You may apply for Component A, B, or both. If your application for both Component A and B is ranked top, Component B will be awarded.
How to apply
- Read the full notice and attachments on Grants.gov. The notice is the official source for deadlines and requirements.
- Make sure your organization has an active SAM.gov registration and Unique Entity ID; registration can take several weeks.
- Register on Grants.gov and submit through Workspace before the deadline and time given in the notice. Our application guide walks through each step.
Questions go to Centers for Disease Control and Prevention - ERA, RYork@cdc.gov, 404-498-2015.
Questions people ask
Who can apply for Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases?
Centers for Disease Control and Prevention - ERA accepts applications from nonprofits, colleges and universities, state and local governments, tribes and businesses.
What is the deadline for Emerging Infections Network - Research for Preventing, Detecting, and Managing Travel-associated Infectious Diseases?
Closes November 5, 2026 (5 days left). Confirm the date and time in the official notice on Grants.gov.
How much funding is available?
Awards of up to $6.0 million each. About $30.0 million in total across about 2 awards.
Similar open grants
- Continuation of the Collaborative Islet Transplantation Registry (U01 Clinical Trial Not allowed)
- BRAIN Initiative Cell Atlas Network (BICAN): Coordinating Unit for Biostatistics, Informatics, and Engagement (CUBIE)
- Centers without Walls for mechanisms of neurodegeneration in Alzheimer’s disease-related dementias (ADRD)
- Expanding the Therapeutic Pipeline for Treating and Preventing Alzheimer's Disease and Related Dementias: Preclinical Validation and Drug Discovery for Novel Candidate Targets (U01 Clinical Trial Not Allowed)
- Systematic Testing of Radionuclides in Preclinical Experiments (STRIPE, RP1 Clinical Trial Not Allowed)
- Exposomic Contributions to ADRD Pathology and Resilience